Not medical advice. Talk to your provider before using any peptide. Full disclaimer
Peptide Schedule Research TeamReviewed Apr 7, 20268 Citations
Pemvidutide (ALT-801) Dosage Calculator
Weight Loss · Phase 2 · Grade C · ~4-6 days half-life (estimated) · Injection
Pemvidutide (ALT-801) Dosage
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 1.2 mg | Weekly |
| Moderate | 1.8 mg | Weekly |
| Aggressive | 2.4 mg | Weekly |
Cycle: No scheduled off period.
No syringe calculation for this route
Subcutaneous
Pemvidutide (ALT-801) has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 1.2 mg to 2.4 mg per administration, weekly.
If your product does arrive as a powder, use the universal reconstitution calculator and enter your own vial size and water volume.
About Pemvidutide (ALT-801)
Beginner, moderate, and aggressive dosing amounts with timing. Free to use.
Pemvidutide (ALT-801) combines GLP-1 and glucagon receptor activation in a single weekly injection. Phase 2 data: 15.6% weight loss plus up to 76% liver fat reduction. FDA Breakthrough Therapy Designation for MASH granted January 2026. Currently, clinical trial access only.
View side effects and safety warnings →
Quick-Start: How to Use Pemvidutide (ALT-801)
- 1Inject subcutaneously once weekly into the abdomen, thigh, or upper arm. Pick the same day each week and rotate injection sites.
- 2Use a 29-31 gauge insulin syringe (0.5 mL or 1 mL). If reconstituting research-grade material: 5 mg vial plus 2 mL bacteriostatic water gives 2.5 mg/mL. For 1.2 mg, draw to 48 units. For 1.8 mg, draw to 72 units. For 2.4 mg, draw to 96 units. With a 10 mg vial plus 2 mL, those same doses are 24, 36, and 48 units.
- 3Clean the injection site with an alcohol swab. Pinch a fold of skin and insert the needle at a 45-90 degree angle. Inject slowly.
Pemvidutide (ALT-801) Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 1.2 mg | Weekly |
| Moderate | 1.8 mg | Weekly |
| Aggressive | 2.4 mg | Weekly |
Pemvidutide isn't available from any consumer or grey-market source. The EuPort lipidated/albumin-conjugated structure can't be synthesized for the research-grade market. Any research-grade product claiming to be pemvidutide is mislabeled or outright fraudulent.
In clinical trials, pre-filled pens were used, so reconstitution wasn't part of the protocol. Research-grade lyophilized material exists only as a lab reagent for preclinical use. For reference, a 5 mg vial plus 2 mL bacteriostatic water gives 2.5 mg/mL. At that concentration, 1.2 mg equals 48 units on a U-100 insulin syringe, 1.8 mg equals 72 units, and 2.4 mg equals 96 units. A 10 mg vial plus 2 mL gives 5 mg/mL, so the same doses become 24, 36, and 48 units respectively.
The non-obvious point: no dose titration was mandated in MOMENTUM. But starting at 1.2 mg for four weeks before escalation is practical given the 52% nausea rate at the top dose. The 2.4 mg arm in MOMENTUM actually did use a four-week 1.2 mg lead-in.
Dosing based on MOMENTUM Phase 2 trial: pemvidutide for 48 weeks in adults with obesity (NCT05295875): 8 published references.View all sources →
Ask AI about this math
Cross-check your Pemvidutide (ALT-801) reconstitution math with AI
Pemvidutide (ALT-801) Cost
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Pemvidutide (ALT-801) Pharmacokinetics
Pharmacokinetics: Active Dose Over Time
t½ = ~4-6 days (estimated)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.
Related Tools
Frequently Asked Questions
How popular is Pemvidutide (ALT-801)?
Emerging. A popularity tier (hot, popular, emerging or niche), based on search volume and community activity.
Reddit: 5. Community mentions on Reddit: <5 (effectively zero).
12 papers on PubMed, the US library of medical research. Search them on PubMed (opens in a new tab).
Low search interest. A band for how often people search Google for the name each month.
These come from this site's peptide records. They are not live counts.